CorMedix Inc
F:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
F:19KA
|
US |
|
F
|
Fortuna Silver Mines Inc
F:F4S
|
CA |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 17.87 EUR with a low forecast of 15 EUR and a high forecast of 22.79 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
17.87
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 17.87 EUR with a low forecast of 15 EUR and a high forecast of 22.79 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
4%
The compound annual growth rate for Revenue over the next 3 years is 4%.
What is the Gross Profit forecast for CorMedix Inc?
Projected CAGR
-1%
The compound annual growth rate for Gross Profit over the next 3 years is -1%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
-25%
The compound annual growth rate for Operating Income over the next 3 years is -25%.
What is the Pre-Tax Income forecast for CorMedix Inc?
Projected CAGR
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
-36%
The compound annual growth rate for Net Income over the next 3 years is -36%.
